These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 18830415)

  • 1. Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice.
    Montgomery RL; Potthoff MJ; Haberland M; Qi X; Matsuzaki S; Humphries KM; Richardson JA; Bassel-Duby R; Olson EN
    J Clin Invest; 2008 Nov; 118(11):3588-97. PubMed ID: 18830415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
    Pellieux C; Aasum E; Larsen TS; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
    J Mol Cell Cardiol; 2006 Sep; 41(3):459-66. PubMed ID: 16859699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy.
    Kee HJ; Eom GH; Joung H; Shin S; Kim JR; Cho YK; Choe N; Sim BW; Jo D; Jeong MH; Kim KK; Seo JS; Kook H
    Circ Res; 2008 Nov; 103(11):1259-69. PubMed ID: 18849323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy.
    Akki A; Seymour AM
    Cardiovasc Res; 2009 Feb; 81(3):610-7. PubMed ID: 19028723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual roles of histone deacetylases in the control of cardiac growth.
    McKinsey TA; Olson EN
    Novartis Found Symp; 2004; 259():132-41; discussion 141-5, 163-9. PubMed ID: 15171251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation.
    Olson EN; Backs J; McKinsey TA
    Novartis Found Symp; 2006; 274():3-12; discussion 13-9, 152-5, 272-6. PubMed ID: 17019803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylases 1 and 2 are expressed at distinct stages of neuro-glial development.
    MacDonald JL; Roskams AJ
    Dev Dyn; 2008 Aug; 237(8):2256-67. PubMed ID: 18651664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development.
    Chang S; McKinsey TA; Zhang CL; Richardson JA; Hill JA; Olson EN
    Mol Cell Biol; 2004 Oct; 24(19):8467-76. PubMed ID: 15367668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure.
    Gallo P; Latronico MV; Gallo P; Grimaldi S; Borgia F; Todaro M; Jones P; Gallinari P; De Francesco R; Ciliberto G; Steinkühler C; Esposito G; Condorelli G
    Cardiovasc Res; 2008 Dec; 80(3):416-24. PubMed ID: 18697792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10.
    Chang S; Young BD; Li S; Qi X; Richardson JA; Olson EN
    Cell; 2006 Jul; 126(2):321-34. PubMed ID: 16873063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase 3 (hdac3) is specifically required for liver development in zebrafish.
    Farooq M; Sulochana KN; Pan X; To J; Sheng D; Gong Z; Ge R
    Dev Biol; 2008 May; 317(1):336-53. PubMed ID: 18367159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac gene expression profile and lipid accumulation in response to starvation.
    Suzuki J; Shen WJ; Nelson BD; Selwood SP; Murphy GM; Kanehara H; Takahashi S; Oida K; Miyamori I; Kraemer FB
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E94-E102. PubMed ID: 12067848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted deletion of thioredoxin-interacting protein regulates cardiac dysfunction in response to pressure overload.
    Yoshioka J; Imahashi K; Gabel SA; Chutkow WA; Burds AA; Gannon J; Schulze PC; MacGillivray C; London RE; Murphy E; Lee RT
    Circ Res; 2007 Dec; 101(12):1328-38. PubMed ID: 17916779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD36 expression contributes to age-induced cardiomyopathy in mice.
    Koonen DP; Febbraio M; Bonnet S; Nagendran J; Young ME; Michelakis ED; Dyck JR
    Circulation; 2007 Nov; 116(19):2139-47. PubMed ID: 17967771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting histone deacetylases for heart failure.
    Bush EW; McKinsey TA
    Expert Opin Ther Targets; 2009 Jul; 13(7):767-84. PubMed ID: 19466913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor.
    Sun Z; Feng D; Fang B; Mullican SE; You SH; Lim HW; Everett LJ; Nabel CS; Li Y; Selvakumaran V; Won KJ; Lazar MA
    Mol Cell; 2013 Dec; 52(6):769-82. PubMed ID: 24268577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switch from actin alpha1 to alpha2 expression and upregulation of biomarkers for pressure overload and cardiac hypertrophy in taurine-deficient mouse heart.
    Warskulat U; Andrée B; Lüsebrink J; Köhrer K; Häussinger D
    Biol Chem; 2006; 387(10-11):1449-54. PubMed ID: 17081118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury.
    Dyck JR; Hopkins TA; Bonnet S; Michelakis ED; Young ME; Watanabe M; Kawase Y; Jishage K; Lopaschuk GD
    Circulation; 2006 Oct; 114(16):1721-8. PubMed ID: 17030679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway.
    Meng RS; Pei ZH; Yin R; Zhang CX; Chen BL; Zhang Y; Liu D; Xu AL; Dong YG
    Eur J Pharmacol; 2009 Oct; 620(1-3):63-70. PubMed ID: 19699196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway.
    Xu Z; Tong Q; Zhang Z; Wang S; Zheng Y; Liu Q; Qian LB; Chen SY; Sun J; Cai L
    Clin Sci (Lond); 2017 Aug; 131(15):1841-1857. PubMed ID: 28533215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.